About flora growth corp - FLGC
Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.
FLGC At a Glance
Flora Growth Corp.
3230 West Commercial Boulevard
Fort Lauderdale, Florida 33309
| Phone | 1-954-842-4989 | Revenue | 59.51M | |
| Industry | Pharmaceuticals: Other | Net Income | -15,907,000.00 | |
| Sector | Health Technology | Employees | 76 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
FLGC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.212 |
| Price to Book Ratio | 4.228 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.964 |
| Enterprise Value to Sales | 0.193 |
| Total Debt to Enterprise Value | 0.427 |
FLGC Efficiency
| Revenue/Employee | 782,960.526 |
| Income Per Employee | -209,302.632 |
| Receivables Turnover | 8.149 |
| Total Asset Turnover | 2.387 |
FLGC Liquidity
| Current Ratio | 1.049 |
| Quick Ratio | 0.743 |
| Cash Ratio | 0.321 |
FLGC Profitability
| Gross Margin | -1.195 |
| Operating Margin | -21.314 |
| Pretax Margin | -27.03 |
| Net Margin | -26.732 |
| Return on Assets | -63.816 |
| Return on Equity | -291.497 |
| Return on Total Capital | -169.044 |
| Return on Invested Capital | -229.125 |
FLGC Capital Structure
| Total Debt to Total Equity | 108.647 |
| Total Debt to Total Capital | 52.072 |
| Total Debt to Total Assets | 18.683 |
| Long-Term Debt to Equity | 44.989 |
| Long-Term Debt to Total Capital | 21.562 |